GFT Technologies SE (WBO:GFT) (Q2 2024) Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

GFT Technologies SE reports an 11% revenue increase and strategic advancements, despite facing sector-specific hurdles and market volatility.

Author's Avatar
Oct 09, 2024
Summary
  • Revenue: EUR 429.6 million, up 11% year-over-year.
  • Adjusted EBIT: EUR 36 million, up 15% year-over-year.
  • Order Backlog: Increased by 19%, including the Sophos acquisition.
  • EBT: EUR 30 million, consistent with the previous year.
  • Banking Sector Revenue: Increased by 16 percentage points, now 76% of total revenue.
  • Insurance Sector Revenue: Decreased by 7% year-over-year.
  • Industry and Others Revenue: Grew by 12%, representing 10% of total revenue.
  • Personnel Expenses and Freelancers Ratio: 84.5% of revenue, up from 81.9% last year.
  • Net Cash Position: Decreased to minus EUR 108 million due to the Sophos acquisition.
  • Cash Flow from Operating Activities: Minus EUR 5.3 million, improved from minus EUR 10 million last year.
  • Employee Numbers: Increased by 20% due to the Sophos integration and growth in Brazil, India, and Spain.
  • Utilization Rate: 89.9%, similar to last year but impacted by underutilization in high-priced countries.
  • Revenue Guidance for 2024: Expected at EUR 885 million, up 12% from last year.
  • Adjusted EBIT Guidance for 2024: Expected to increase by 12% to EUR 82 million.
Article's Main Image

Release Date: August 08, 2024

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • GFT Technologies SE (WBO:GFT, Financial) reported an 11% revenue growth to EUR 430 million in the first half of 2024, with an adjusted EBIT margin increase of 15% to EUR 36 million.
  • The company experienced strong organic growth in Brazil, with a 12% increase, highlighting the benefits of geographic diversification.
  • The integration of Sophos is on track, contributing to an increased order backlog and supporting the revised guidance.
  • GFT's AI.DA marketplace and AI Impact product have gained significant market interest, contributing to 8% of total revenues.
  • The company received prestigious awards for its Engenion product and was recognized by ISG for its data and analytics services, enhancing its market credibility.

Negative Points

  • The Anglo-Saxon markets, particularly the UK and North America, showed weakness, impacting overall growth.
  • The insurance sector experienced a 7% decline due to the completion of large projects and difficulty in rebuilding the pipeline.
  • Capacity adjustments were necessary in high-cost regions like the UK, leading to increased restructuring costs.
  • The Sophos acquisition did not meet initial revenue expectations, contributing less to the EBITDA than anticipated.
  • Underutilization in high-priced countries affected profitability, with a noticeable impact on the operating margin.

Q & A Highlights

Q: How does the Sophos integration align with the reduction in full-year EBITDA contribution?
A: The reduction in EBITDA contribution from Sophos is due to a decrease in expected revenue, influenced by the Anglo-Saxon markets, particularly North America. The initial goal was EUR 60 million in revenues, now adjusted to EUR 55 million.

Q: What impact does the Brazilian accounting effect have on the EBT guidance?
A: EUR 3 million from the Brazilian provision was included in the EBT and EBIT adjusted guidance.

Q: Is the AI.DA product portfolio gaining traction reflected in the order book or sales?
A: Yes, AI.DA is generating real revenues, with AI Impact and other AI solutions contributing to 8% of total revenues.

Q: How is customer behavior affecting project decisions, and what is the wage trend?
A: Customers, especially in Anglo-Saxon markets, are postponing project decisions, impacting growth. Wages are currently stable with no significant inflationary pressure.

Q: What is the outlook for the second half of the year regarding utilization and capacity adjustments?
A: Utilization is expected to improve to 91% or higher. Capacity adjustments could result in EUR 1.5 million to EUR 3 million in costs, which is included in the guidance.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.